Matinas BioPharma exchanges 466,666 warrants for common stock; cancels $17.50 strike warrants

Matinas BioPharma Holdings, Inc.

Entered into Warrant Exchange Agreements on Aug 15, 2025 with certain warrant holders.
Issued 466,666 shares of common stock in exchange for an equal number of warrants with $17.50 exercise price.
Warrants were originally issued on April 5, 2024; after exchange, all such warrants are cancelled.
Exchange was exempt from registration under Section 3(a)(9); no cash consideration involved.
Shares issued without restrictive legends and are freely tradable under federal securities laws.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.